[{"AccountsPayableCurrent_0_Q3_USD":7882000.0,"AvailableForSaleSecuritiesNoncurrent_0_Q3_USD":3275000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":1344000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":17953000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":52100000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":19162000.0,"OtherLiabilitiesCurrent_0_Q3_USD":4645000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_3_Q3_USD":333828000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":420819000.0,"RestrictedCashCurrent_0_Q3_USD":2417000.0,"IncreaseDecreaseInOtherCurrentLiabilities_3_Q3_USD":-651000.0,"AvailableForSaleSecuritiesGrossUnrealizedGains_3_Q3_USD":720000.0,"AvailableForSaleSecuritiesAmortizedCost_0_Q3_USD":533214000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":-35000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-507000.0,"IncreaseDecreaseInAccountsPayableTrade_3_Q3_USD":-2821000.0,"AvailableForSaleSecuritiesCurrent_0_Q3_USD":113523000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":6925000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":1025000.0,"LongTermDebt_0_Q3_USD":102656000.0,"LongTermDebtNoncurrent_0_Q3_USD":73880000.0,"OtherAssetsNoncurrent_0_Q3_USD":874000.0,"PaymentsOfDebtIssuanceCosts_3_Q3_USD":130000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":688061.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_3_Q3_USD":375000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":4466000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_3_Q3_USD":82508000.0,"CashEquivalentsAtCarryingValue_0_Q3_USD":417136000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-60388000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-185782000.0,"TaxesPayableCurrent_0_Q3_USD":0.0,"InterestExpenseDebt_3_Q3_USD":26156000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q3_USD":36889000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-37000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":19639000.0,"AmortizationOfFinancingCostsAndDiscounts_3_Q3_USD":1243000.0,"OperatingLeaseCost_1_Q3_USD":3100000.0,"OperatingLeaseCost_3_Q3_USD":9300000.0,"OperatingLeaseLiability_0_Q3_USD":85084000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":4645000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":80439000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":51337000.0,"NoninterestIncome_3_Q3_USD":5251000.0,"OperatingLeasesIncomeStatementDepreciationExpenseOnPropertySubjectToOrHeldForLease_3_Q3_USD":3800000.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":57936000.0,"ReceivablesNetCurrent_0_Q3_USD":14130000.0,"RestrictedCashAndCashEquivalentsAtCarryingValue_0_Q3_USD":420819000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q3_USD":2417000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":205000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q3_USD":2266000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3_Q3_USD":5163000.0,"CostOfGoodsAndServicesSold_1_Q3_USD":513000.0,"NoninterestIncome_1_Q3_USD":881000.0,"NoninterestExpense_1_Q3_USD":2291000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":533934000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_3_Q3_USD":116187000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_3_Q3_USD":1344000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":126355000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q3_USD":60507000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q3_USD":13368000.0,"NoninterestExpense_3_Q3_USD":6887000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":12948000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":12222000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":2885000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":41271000.0,"LossContingencyAccrualProvision_3_Q3_USD":0.0,"LossContingencyLossInPeriod_3_Q3_USD":0.0,"MarketableSecuritiesUnrealizedGainLoss_1_Q3_USD":-507000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":12584000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":65.84,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":25.1,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":42.1,"LiabilitiesAndStockholdersEquity_0_Q3_USD":691264000.0,"LiabilitiesCurrent_0_Q3_USD":77946000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":11281000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":271702000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-166796000.0,"NetIncomeLoss_1_Q3_USD":-59881000.0,"Liabilities_0_Q3_USD":233609000.0,"NetIncomeLoss_3_Q3_USD":-185747000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":14801000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":38697000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-924663000.0,"StockholdersEquity_0_Q3_USD":457655000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":61573877.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":61160984.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":4190000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":47466000.0,"InventoryNet_0_Q3_USD":33808000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":11493000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":720000.0,"AdditionalPaidInCapital_0_Q3_USD":1381537000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":6013547.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":6013547.0,"Assets_0_Q3_USD":691264000.0,"AssetsCurrent_0_Q3_USD":594664000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":1764000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":418402000.0,"CommonStockSharesOutstanding_0_Q3_shares":61756658.0,"CommonStockValue_0_Q3_USD":61000.0,"CostsAndExpenses_1_Q3_USD":95200000.0,"CostsAndExpenses_3_Q3_USD":266306000.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.97,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-3.04,"CommonStockSharesIssued_0_Q3_shares":61756658.0,"VariableLeaseCost_1_Q3_USD":700000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"CommonStockSharesAuthorized_0_Q3_shares":150000000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":8494000.0,"IncreaseDecreaseInInventories_3_Q3_USD":30853000.0,"InventoryFinishedGoods_0_Q3_USD":1410000.0,"InventoryRawMaterials_0_Q3_USD":9043000.0,"InventoryWorkInProcess_0_Q3_USD":23355000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":11841000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":3312000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":47191000.0,"DebtInstrumentUnamortizedDiscount_0_Q3_USD":300000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-1570000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-1949000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_3_Q3_shares":355861.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_3_Q3_USD":52.59,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":3416050.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":3411000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"StockIssuedDuringPeriodValueRestrictedStockAwardGross_1_Q3_USD":-2990000.0,"ShareBasedCompensation_3_Q3_USD":52100000.0,"DebtInstrumentCarryingAmount_0_Q3_USD":75000000.0,"IncreaseDecreaseInOtherAccruedLiabilities_3_Q3_USD":2299000.0,"InterestPaidNet_3_Q3_USD":5144000.0,"OperatingIncomeLoss_1_Q3_USD":-58311000.0,"OperatingIncomeLoss_3_Q3_USD":-183798000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":490010.0,"PreferredStockSharesAuthorized_0_Q3_shares":5000000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"PreferredStockValue_0_Q3_USD":null,"ResearchAndDevelopmentExpense_1_Q3_USD":40196000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":114054000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":54491000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":151227000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"VariableLeaseCost_3_Q3_USD":2000000.0,"Ticker":"GBT","CIK":"1629137","name":"GLOBAL BLOOD THERAPEUTICS, INC.","OfficialName":"Global Blood Therapeutics Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2248655788.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201105"}]